Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 8/20 | 0.61 |
| ▸ | CCR1 | P32246 | 4/20 | 0.61 |
| ▸ | CCR8 | P51685 | 4/20 | 0.61 |
| ▸ | MMP2 | P08253 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | METAP2 | P50579 | 2/20 | 0.53 |
| ▸ | METAP1 | P53582 | 2/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | COMT | P21964 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.52 |
| ▸ | HTT | P42858 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29683521 | 1.00 | L3MBTL1 (0.61) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL28229074 | 0.86 | ALDH1A1 (0.62) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL1408764 | 0.86 | TRPM4 (0.55) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL170139 | 0.84 | ALDH1A1 (0.59) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL27863256 | 0.83 | CCR1 (0.49) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL17174163 | 0.82 | MMP2 (0.45) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL12914331 | 0.81 | L3MBTL1 (0.68) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL17174165 | 0.79 | KDM4E (0.44) | L3MBTL1CCR1CCR8MMP2TSHR | |
| SCHEMBL1302713 | 0.78 | TRPM4 (0.55) | L3MBTL1MMP2TSHRMETAP2METAP1 | |
| SCHEMBL169671 | 0.78 | CCR1 (0.62) | L3MBTL1CCR1CCR8MMP2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107630239-B | Indium electroplating compositions containing 1, 10-phenanthroline compounds and methods of electroplating indium | 罗门哈斯电子材料有限责任公司 | 2020-11-06 | — | — | CN | claimed |
| EP-3272910-B1 | INDIUM ELECTROPLATING COMPOSITIONS CONTAINING 1,10-PHENANTHROLINE COMPOUNDS AND METHODS OF ELECTROPLATING INDIUM | ROHM & HAAS ELECT MAT (US) | 2018-09-26 | — | — | EP | claimed |
| EP-3272910-A1 | INDIUM ELECTROPLATING COMPOSITIONS CONTAINING 1,10-PHENANTHROLINE COMPOUNDS AND METHODS OF ELECTROPLATING INDIUM | Rohm and Haas Electronic Materials LLC (US) | 2018-01-24 | — | — | EP | claimed |
| US-8652752-B2 | Sulphonium salt initiators | BASF SE (DE) | 2014-02-18 | — | — | US | claimed |
| EP-2197840-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-11-06 | — | — | EP | claimed |
| US-20100297540-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-11-25 | — | — | US | claimed |
| EP-2197869-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-06-23 | — | — | EP | claimed |
| WO-2009047105-A1 | SULPHONIUM SALT INITIATORS | BASF SE (CH) | 2009-04-16 | — | — | WO | claimed |
| EP-1251346-B1 | Sensors for the determination of organometallic compounds | DYNASOL ELASTOMEROS SA (ES) | 2008-10-15 | — | — | EP | claimed |
| EP-1251346-A1 | Sensors for the determination of organometallic compounds | Dynasol Elastomeros, S.A. (ES) | 2002-10-23 | — | — | EP | claimed |
| US-20020151081-A1 | Sensors for the determination of organometallic compounds | DYNASOL ELASTOMEROS, S.A. | 2002-10-17 | — | — | US | claimed |
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| CN-118307514-A | Organic electroluminescent compound and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024120442-A1 | PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024120466-A1 | MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SURIO THERAPEUTICS CO., LTD (CN) | 2024-06-13 | — | — | WO | disclosed |
| WO-1998032756-A1 | SUBSTITUTED AMINOALKYLIDENAMINO TRIAZINES AS HERBICIDES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-07-30 | — | — | WO | disclosed |
| US-5773631-A | PROTECTION OF POLYMERS AND LUBRICANTS AGAINST THERMAL, OXIDATIVE OR LIGHT INDUCED DEGRDATION | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0842975-A1 | Stabilising polyolefins for long term contact with an extracting medium | Ciba SC Holding AG (CH) | 1998-05-20 | — | — | EP | disclosed |
| EP-0839623-A1 | Stabiliser combination for rotomolding process | Ciba SC Holding AG (CH) | 1998-05-06 | — | — | EP | disclosed |
| US-5516920-A | POLYMER STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1996-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297540-A1 | SULPHONIUM SALT INITIATORS | SULT1A1, SULT2A1, NCOA1 | L3MBTL1 20/4885CCR1 506/4885CCR8 2432/4885 |
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | L3MBTL1 233/4885CCR1 118/4885CCR8 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.